NOV Stock Analysis: NOV | NYSE
Oil & Gas Equipment & Services | NYSE, USA | Market Cap: 6.773m USD | 12M Return: 52% | US62955J1034 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 63.8M
EPS Trend: -79.6%
Qual. Beats: 0
Rev. Trend: 26.2%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NOV Inc. is a global provider of equipment, components, and services for oil and gas drilling and production, as well as industrial and renewable energy applications. The company operates through two segments-Energy Equipment and Energy Products and Services-offering a broad portfolio that includes drill bits, downhole tools, pumps, tubular coatings, drilling rigs, subsea pipe systems, and processing and separation equipment. Headquartered in Houston, Texas, and founded in 1862, the company was previously known as National Oilwell Varco before rebranding to NOV Inc. in January 2021.
Operating in the Oil & Gas Equipment & Services sub-industry, NOV serves upstream exploration and production customers as well as adjacent industrial markets. The energy services sector is highly cyclical, with demand closely tied to global oil prices and rig activity levels. NOVs diversification into renewable energy and industrial end-markets reflects a broader industry trend among oilfield equipment manufacturers seeking to reduce exposure to drilling-cycle volatility.
- North American rig count recovery drives drill pipe and bits demand
- Middle East and offshore project awards expand international backlog
- Capital returns continue with share repurchases and dividends
| Net Income: 96.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.98 > 1.0 |
| NWC/Revenue: 39.34% < 20% (prev 40.30%; Δ -0.95% < -1%) |
| CFO/TA 0.08 > 3% & CFO 916.0m > Net Income 96.0m |
| Net Debt (1.78b) to EBITDA (782.0m): 2.28 < 3 |
| Current Ratio: 2.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (364.0m) vs 12m ago -3.19% < -2% |
| Gross Margin: 20.53% > 18% (prev 21.10%; Δ -0.57% > 0.5%) |
| Asset Turnover: 76.58% > 50% (prev 77.36%; Δ -0.78% > 0%) |
| Interest Coverage Ratio: 4.80 > 6 (EBIT TTM 418.0m / Interest Expense TTM 87.0m) |
| A: 0.30 (Total Current Assets 5.79b - Total Current Liabilities 2.39b) / Total Assets 11.2b |
| B: -0.06 (Retained Earnings -639.0m / Total Assets 11.2b) |
| C: 0.04 (EBIT TTM 418.0m / Avg Total Assets 11.3b) |
| D: 1.26 (Book Value of Equity 6.21b / Total Liabilities 4.94b) |
| Altman-Z'' = 3.37 = A |
| DSRI: 0.72 (Receivables 1.81b/2.56b, Revenue 8.64b/8.79b) |
| GMI: 1.03 (GM 21.10% / 20.53%) |
| AQI: 0.96 (AQ_t 0.26 / AQ_t-1 0.27) |
| SGI: 0.98 (Revenue 8.64b / 8.79b) |
| TATA: -0.07 (NI 96.0m - CFO 916.0m) / TA 11.2b) |
| Beneish M = -3.27 (Cap -4..+1) = AA |
As of October 13, 2026, the stock is trading at USD 18.89 with a total of 3,125,900 shares traded. Over the past week, the price has changed by -3.18%, over one month by -8.03%, over three months by -0.84% and over the past year by +52.00%.
Current recommended Stop Loss: 18.10 (which is 4.2% or 1.4 ATR below the current price).
NOV has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold NOV.
- StrongBuy: 5
- Buy: 3
- Hold: 10
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 22.1 | 17.2% |
P/E Trailing = 70.3704
P/E Forward = 15.6006
P/S = 0.784
P/B = 1.1651
P/EG = 0.8185
Revenue TTM = 8.64b USD
EBIT TTM = 418.0m USD
EBITDA TTM = 782.0m USD
Long Term Debt = 1.69b USD (from longTermDebt, last quarter)
Short Term Debt = 114.0m USD (from shortTermDebt, last quarter)
Debt = 2.95b USD (from shortLongTermDebtTotal, last quarter) + Leases 620.0m
Net Debt = 1.78b USD (calculated: Debt 2.95b - CCE 1.16b)
Enterprise Value = 8.56b USD (6.77b + Debt 2.95b - CCE 1.16b)
Interest Coverage Ratio = 4.80 (Ebit TTM 418.0m / Interest Expense TTM 87.0m)
EV/FCF = 15.22x (Enterprise Value 8.56b / FCF TTM 562.0m)
FCF Yield = 6.57% (FCF TTM 562.0m / Enterprise Value 8.56b)
FCF Margin = 6.51% (FCF TTM 562.0m / Revenue TTM 8.64b)
Net Margin = 1.11% (Net Income TTM 96.0m / Revenue TTM 8.64b)
Gross Margin = 20.53% ((Revenue TTM 8.64b - Cost of Revenue TTM 6.87b) / Revenue TTM)
Gross Margin QoQ = 24.41% (prev 18.47%)
Tobins Q-Ratio = 0.76 (Enterprise Value 8.56b / Total Assets 11.2b)
Interest Expense / Debt = 2.95% (Interest Expense 87.0m / Debt 2.95b)
Taxrate = 26.11% (41.0m / 157.0m)
NOPAT = 308.8m (EBIT 418.0m * (1 - 26.11%))
Current Ratio = 2.42 (Total Current Assets 5.79b / Total Current Liabilities 2.39b)
Debt / Equity = 0.47 (Debt 2.95b / totalStockholderEquity, last quarter 6.21b)
Debt / EBITDA = 2.28 (Net Debt 1.78b / EBITDA 782.0m)
Debt / FCF = 3.17 (Net Debt 1.78b / FCF TTM 562.0m)
Total Stockholder Equity = 6.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.85% (Net Income 96.0m / Total Assets 11.2b)
RoE = 1.53% (Net Income TTM 96.0m / Total Stockholder Equity 6.29b)
RoCE = 5.24% (EBIT 418.0m / Capital Employed (Equity 6.29b + L.T.Debt 1.69b))
RoIC = 3.64% (NOPAT 308.8m / Invested Capital 8.49b)
WACC = 7.22% (E(6.77b)/V(9.72b) * Re(9.41%) + D(2.95b)/V(9.72b) * Rd(2.95%) * (1-Tc(0.26)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.07 | Cagr: -3.78%
[DCF] Terminal Value 73.10% ; FCFF base≈700.8m ; Y1≈614.6m ; Y5≈496.5m
[DCF] Fair Price = 17.36 (EV 7.97b - Net Debt 1.78b = Equity 6.19b / Shares 356.5m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -79.63 | EPS CAGR: -61.56% | SUE: 0.55 | # QB: 0
Revenue Correlation: 26.16 | Revenue CAGR: 0.56% | SUE: 1.08 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.25 | Chg30d=+0.00% | Revisions=+0% | Analysts=13
EPS current Year (2026-12-31): EPS=0.89 | Chg30d=-0.27% | Revisions=+56% | GrowthEPS=+128.6% | GrowthRev=-1.0%
EPS next Year (2027-12-31): EPS=1.26 | Chg30d=-0.24% | Revisions=+19% | GrowthEPS=+41.1% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: +31% (up=24, down=12)